Fingerprint
Dive into the research topics of 'Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib
John Nemunaitis, Sebastian Bauer, Jean Yves Blay, Khalil Choucair, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret Von Mehren, John Zalcberg, Haroun Achour, Rodrigo Ruiz-Soto, Michael C. Heinrich
Research output: Contribution to journal › Article › peer-review
45
Scopus
citations